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CaV1.2 L-type calcium channel
Primary cilia
Modiﬁer geneIn polycystic kidney disease (PKD), abnormal proliferation and genomic instability of renal epithelia have been
associated with cyst formation and kidney enlargement. We recently showed that L-type calcium channel
(CaV1.2) is localized to primary cilia of epithelial cells. Previous studies have also shown that low intracellular cal-
cium levelwas associatedwith the hyperproliferation phenotype in the epithelial cells. However, the relationship
between calcium channel and cystic kidney phenotype is largely unknown. In this study, we generated cells with
somatic deﬁcient Pkd1 or Pkd2 to examine ciliary CaV1.2 function via lentiviral knockdown or pharmacological
verapamil inhibition. Although inhibition of CaV1.2 expression or function did not change division and growth
patterns in wild-type epithelium, it led to hyperproliferation and polyploidy in mutant cells. Lack of CaV1.2 in
Pkd mutant cells also decreased the intracellular calcium level. This contributed to a decrease in CaM kinase
activity, which played a signiﬁcant role in regulating Akt and Erk signaling pathways. Consistent with our
in vitro results, CaV1.2 knockdown in zebraﬁsh and Pkd1 heterozygous mice facilitated the formation of kidney
cysts. Larger cysts were developed faster in Pkd1 heterozygous mice with CaV1.2 knockdown. Overall, our ﬁnd-
ings emphasized the importance of CaV1.2 expression in kidneys with somatic Pkdmutation.We further suggest
that CaV1.2 could serve as a modiﬁer gene to cystic kidney phenotype.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Polycystic kidney disease (PKD) is one of the most common genetic
diseases. It is characterized by formation and expansion of multiple
ﬂuid-ﬁlled cysts in the kidneys. Many previous studies have suggested
that the abnormality of kidney cystic cells is contributed by interrupted
calciumhomeostasis [1–4], probably due to the abnormal calcium chan-
nel polycystin-2 (PC2) or its regulatory protein polycystin-1 (PC1).
Both PC1 and PC2 are localized to primary cilia of renal epithelia and
are required for calcium signaling [5–7]. Cells isolated from the cyst lin-
ing of human patients and PKD animal models have been shown to lack
normal ﬂow-sensitive calcium signaling and have lower intracellular
calcium concentration. This low calcium level has been thought to be
critical for pathogenesis of PKD [2]. In cystic kidney-derived cells, the
aberrant intracellular calcium level has been shown to cause cAMP-
dependent activation of theMEK/ERKpathway and increased cell prolif-
eration [4,8,9]. In contrast, cAMP often inhibits theMEK/ERK pathway in
normal kidney cells. Calcium concentration has long been thought to bepartment of Pharmacology; MS
on Ave, Toledo, OH 43614, USA.
.amajor factor that differentiates the roles of cAMP between normal and
cystic kidney cells. Furthermore, PKD phenotypes could be partially
rescued by recovering intracellular calcium level, whereas reduction of
that could reproduce PKD phenotypes [2–4].
One of the major complications of PKD is hypertension, occurring in
50 to 70% of cases before any signiﬁcant reduction in glomerular ﬁltra-
tion rate, with an average onset at 30 years of age [10]. Abnormalities
in the renin–angiotensin system and vascular endothelial cilia have
been proposed as themechanisms of hypertension [11–13]. Because hy-
pertension in PKD is still poorly understood, the hypertensive therapy
has not been much different than therapy for hypertension in other
chronic kidney diseases. L-type calcium channel blockers have been
tested in PKD patients to control their blood pressure [14,15]. Consider-
ing the fact that calcium level is lower in cystic than normal epithelia
[1–4], understanding the roles of L-type calcium channel in PKD is scien-
tiﬁcally and clinically imperative.When heterozygousHan:SPRD Cy rats
were treated with a serial of L-type calcium channel blockers to inhibit
its largest subunit (CaV1.2), larger cystswere observed at amuch earlier
stage in treated- than in non-treated groups [1,16]. However, themolec-
ular mechanism of CaV1.2 in the kidney remains largely unknown. In
the present study, we examined the roles of CaV1.2 in the cilia and in
cystic kidney formation in orthologous models of ADPKD. Our study
suggested a potential role of CaV1.2 as a modiﬁer gene in cystic renal
epithelial cells.
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2.1. Cell culture
Mouse kidney epithelial cells (wild-type, Pkd1−/− and Pkd2−/−)
were isolated from embryonic day 15.5 kidneys from a cross of
Pkd1+/− or Pkd2+/−mice that also carried a temperature-sensitive sim-
ian virus 40 (SV40) large T-antigen transgene. The heterozygousmice of
Pkd1 or Pkd2 had normal characteristics as of wild-type mice. Because a
mouse body temperature is about 39 °C, the SV40 transgene remained
inactivated. Of note is that the transgene was activated at 33 °C and in
the presence of IFN-γ. Therefore, the resulting cells from these mice
were considered conditionally immortalized, because the expression
of the SV40 large T-antigen could be regulated by temperature and
IFN-γ in culture. All cell lines were further cloned by positive selection
for renal epithelial marker (wheat germ agglutinin, WGA). Cell lines
were grown at 33 °C in Dulbecco's modiﬁed Eagle's medium containing
10% fetal bovine serum supplemented with IFN-γ. In all experiments, a
constant laminar ﬂow generating a shear-stress of 1 dyn/cm2 was ap-
plied for 18 h to mimic a physiological condition. Such force has been
shown to be able to activate ﬂow-sensitive cell signaling mediated by
primary cilia [17].
2.2. Fluorescence automated cell sorting
Fully differentiated cells were rinsed with HBSS (Hank's balanced
salt solution), and approximately 105 viable cells were analyzed for
expression of an epithelial marker. Cells were incubated with FITC-
conjugated WGA antibody (10 μg/ml; Vector Laboratories) and subject-
ed to a robust analysis using FACStar-PLUS with a laser excitation of
200 mm.
2.3. Lentivirus production and infection
HEK-293T cells were co-transfected with lentivirus packaging plas-
mids mix and one of four different constructs to block CaV1.2 expres-
sion. These constructs were labeled 1 (5′-GTC CAG CAC ACC TCC TTC
AGG AAC CAT AT-3′), 2 (5′-TCA GAA GTG CCT CAC TGT TCT CGT GAC
CT-3′), 3 (5′-TCA GAA GTG CCT CAC TGT TCT CGT GAC CT-3′) or scram-
bled (5′-AAA CCC ATG AGA GAC CTT TTA GAA GAT T-3′). Lentivirus was
harvested at 48 and 72 h after the initial transfection. The titration was
determined to be ~107 with the method described previously [18,19].
One milliliter of each shRNA-lentivirus was added to cells grown on
the10-cmcell culture dishes. The efﬁciency of infectionwasdetermined
with Accuri Flow Cytometer by monitoring the percentage of GFP posi-
tive cells. Gene silencing was further conﬁrmed by Western blot, and
only the shRNA lentiviruswith higher knockdown efﬁciencywas selected
for future use. Infected cell lines were maintained in cell growthmedium
described above and supplementedwith 10 μg/ml of puromycin tomain-
tain homogenous population. For in vitro applications, lentiviruswas con-
centrated to a titration of 109–10 with an established method [20]. The
veriﬁcations of CaV1.2 knockdownwere examined after clonal expansion
at passages 2, 3 and 5. Most of our studies on these cells were carried out
at passages 3 to 6, except for those with verapamil at passage 8.
2.4. Immunoblot analysis
A total protein of 30 mg was analyzed with a standard Western blot.
The following antibodies and dilutions were used in our analyses:
phospho-ERK (Cell Signaling, 1:1000), anti-ERK (Cell Signaling, 1:1000),
phosphor-AKT (Cell Signaling, 1:200), anti-AKT (Cell Signaling, 1:1000),
anti-CaV1.2 (Alomone, 1:500) and GAPDH (Cell Signaling, 1:1500). In
some cases, wild-type cellswere also treatedwith CaMkinase II inhibitor
(10 μM; Sigma Aldrich, Inc.) and KN-93 (2 μM; Sigma Aldrich, Inc.) for 18 h
and 24 h, respectively. Band intensity was quantiﬁed using NIH's ImageJ
software.2.5. Immunoﬂuorescence studies
Cells were ﬁxed with 2% sucrose plus 3% paraformaldehyde, perme-
abilized with 0.5% (vol/vol) Triton-X, and incubated with rabbit Anti-
bodies at 1:200 dilution. To stain CaV1.2, rabbit polyclonal anti-CaV1.2
(Alomone, 1:200) was applied to cells and incubated overnight at 4 °C.
Mouse antibody to acetylated α-tubulin (1:10,000; Sigma Aldrich) was
used as a ciliary marker, and cells were counterstained with 4′,6-
diamidino-2-phenylindole (DAPI; Vector Laboratories) to label the
nuclei. Respective secondary antibodieswere used at a dilution of 1:500.
2.6. Chromosomal analysis
For ﬂow cytometry analysis, cells were harvested and washed with
cold phosphate buffered solution (PBS). Cells were then re-suspended
at 1–2 × 106 cells/ml. One milliliter of cell aliquot was placed in a
15 ml polypropylene. Three milliliters of ethanol was added to the cell
aliquot for ﬁxation at−20 °C overnight. After two washes with PBS, a
solution containing propidium iodide and RNase A was added to a cell
pellet for 3 h at 4 °C. Cells were analyzed with Accuri Flow Cytometer,
as previously described [21,22].
For chromosomal counting, cells were plated for at least one day and
grown to 80% conﬂuence. They were then grown for an additional 2 h
after incubating with 0.05 μg/ml colcemid solution for 30 min at 37 °C
in the dark. Next, cells were collected and incubated with 0.56% KCl
hypotonic solution for 45 min at 37 °C, followed by ﬁxation with 3:1
methanol:acetic acid. The cells were dropped onto pre-cleaned glass
slides and allowed to dry. Dried slides were counterstained with DAPI
for microscopy analysis. At least 50 chromosome spreads were counted
from each cell analysis, as previously described [23]. In some cases,
Pkd1−/− and Pkd2−/− cells were treated with L-type calcium channel
blocker verapamil (2 μM; Sigma Aldrich, Inc.) for 24 h.
2.7. Calcium measurement
Cells were cultured on glass-bottom dishes and perfused 18 h prior
to experiment. After two washes with HBSS, cells were incubated with
5 μM of Fura-2 AM (Telf Labs) for 45 min in the dark. After incubation,
cells were washed and left in HBSS for 15min to allow Fura2-AM to hy-
drolyze. We have previously described details on experimental set-up
and calcium calculation [17].
2.8. Animal models
Adult wild-type AB zebraﬁsh were obtained from the Zebraﬁsh Inter-
national Resource Center (Eugene, OR) and used for breeding. Embryos
were injected with 1 mM antisense translation blocking morpholino
oligos (GeneTools) at the 1–2 cell stage. Zebraﬁsh embryos were then
cultured at 28.5 °C in sterile egg water [24]. The following morpholino
sequences were used: control MO: 5′-CCT CTT ACC TCA GTT ACA ATT
TAT A-3′, cav1.2 MO: 5′-ACA TGT TTT TGC TTT CAT TTA CCA T-3′.
Previously generated Mx1Cre:Pkd1wt/ﬂox mice at two months old
were used in our studies [25]. In addition, only males were selected be-
cause they were shown to be more sensitive to CaV1.2 inhibition [16].
Polyinosine–polycytosine (pIpC, 62.5 μg) was injected intraperitoneally
at seven days of age for ﬁve consecutive days. Pre-concentrated lentivi-
rus (IFU= 109–10/ml) was injected to animals at day 10 after birth sub-
cutaneously. At two months of age, animals were euthanized and their
kidneys were removed for analysis. Kidney samples were ﬁrst cut in
half. One half was used for immunoblotting, while the other half was
for hematoxylin and eosin (H&E) staining.
2.9. Statistical analysis
All data are reported as mean± standard error of mean with statis-
tical power greater than 0.8 at p b 0.05. Data were then analyzed
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performed with Prism GraphPad 5 software.
3. Results
3.1. CaV1.2 was expressed in Pkd1 and Pkd2 cell lines
To conﬁrm the presence of CaV1.2 in renal epithelial cells and deter-
minewhether its expression levelwas altered in different cell lines from
cystic kidneys, we performed immunoblotting for CaV1.2 in wild type,
Pkd1−/− and Pkd2−/− renal epithelial cells; all cell lines expressed
renal epithelial marker, Wheat Germ Agglutinin (data not shown). We
found that CaV1.2was expressed in all cell lines but was two fold higher
inmutant compared towild-type cells (Fig. 1a). To explore if PC1 or PC2
deﬁciency affected CaV1.2 distribution in renal epithelial cilia, we also
studied CaV1.2 localization with immunoﬂuorescence. CaV1.2 was
mainly localized to primary cilia in wild-type cells but was found to be
randomly distributed in the cytoplasm of Pkd cells (Fig. 1b).
3.2. CaV1.2 knockdown shortened cilia length in Pkd epithelial cells
To study the loss-of-function effects of CaF1.2, we transfected renal
epithelial cells with lentivirus carrying different shRNA sequences
speciﬁc for unique regions of mRNA coding for CaV1.2. Among the
three sequences tested, shRNA sequence #3 produced the highest
knockdown efﬁciency (Fig. 2a). This sequence was thus selected for
use in all of our future studies. To explore whether loss of CaV1.2
could play a role in cilia formation, we examined the cilia length in all
cell groups (Fig. 2b). In wild-type cells, we observed no change in cilia
length between control and CaV1.2 knockdown. In contrast, knockdown
of CaV1.2 signiﬁcantly shortened cilia length in Pkd groups. This obser-
vation is intriguing because shorter cilia were often related to less sen-
sitivity to extracellular cues, such as ﬂuid-ﬂow shear stress [26,27].Fig. 1. CaV1.2 was up-regulated in Pkd1−/− and Pkd2−/− cell lines. a. Immunoblot analysis was
CaV1.2 was overexpressed in Pkd cells compared to wild-type cells. GAPDHwas used as loading
localized to cilia inwild-type cells. In Pkd cell lines, CaV1.2was not detected in the cilia. Acetylate
from the control wild-type group.Also noteworthy is that Pkd1−/− and Pkd2−/− cell lines had longer
cilia compared to wild-type cells.3.3. CaV1.2 regulated ﬂow-induced cytosolic calcium level in Pkd epithelial
cells
Despite its unclear physiological function in renal epithelial cells,
CaV1.2 has been proposed to be a physiologically relevant calciumchan-
nel in the kidney [28]. To examine if CaV1.2 regulated cytosolic calcium
concentration in physiological condition, we challenged both CaV1.2
knockdown and control groups of wild-type and Pkd cells with continu-
ous ﬂuid-ﬂow at 0.7 dyn/cm for 18 h (Fig. 3). Therewas no difference in
calcium levels in wild-type cells between control and CaV1.2 knock-
down. On the other hand, CaV1.2 knockdown decreased the already
low calcium concentration in Pkd cell lines.3.4. CaM kinase II activity was regulated by CaV1.2
Calcium ions serve as a very important second messenger in many
signaling pathways. Therefore, we proposed that altered cytosolic calci-
um homeostasis could lead to changes in a signaling cascade. Because
Akt has been shown to be abnormal in tissue samples isolated from
PKD patients [21,22,29], we ﬁrst examined phosphorylated Akt levels
(Fig. 4a). CaV1.2 knockdown did not change the phosphorylation level
of Akt in wild-type cells, whereas it signiﬁcantly reduced Akt phosphor-
ylation in Pkd cells (Fig. 4b). Phosphorylation ERK was consequently in-
creased in CaV1.2 knockdown Pkd cells, consistent with the fact that
inactivated Akt could not inhibit ERK phosphorylation [30]. Because
calcium is an important regulator for CaM kinase II, which also phos-
phorylates and activates Akt [31], we treated wild-type cells with W7
or KN-93 (CaM kinase II inhibitors). As predicted, Akt phosphorylation
was decreased in wild-type cells treated with the inhibitors. We thusperformed to detect CaV1.2 expression inwild-type (WT), Pkd1−/− and Pkd2−/− cell lines.
control. b. Overexpression of CaV1.2 was also conﬁrmed by immunostaining. CaV1.2 was
d-α-tubulin (acet-a-tub)was used as ciliamarker. N=3; * indicates signiﬁcant difference
Fig. 2. CaV1.2 knockdown reduced cilia length in Pkd1−/− and Pkd2−/− cell lines. a. Four different shRNA sequenceswere applied towild-type (WT) cells via lentivirus delivery. The shRNA
sequences speciﬁc for CaV1.2were indicated as 1, 2, or 3, and scramble shRNAwas used as a control (C). Additional non-infected control (NI) was also used. Immunoblotting analysis was
performed to determine CaV1.2 silencing efﬁciency. N= 6. Thus, it was selected for all future applications. N= 6. b. CaV1.2 knockdown had no effect on cilia length in wild-type cells but
shortened cilia in Pkd1−/− and Pkd2−/− cells. N ≥ 20 preparations for each group. #Indicates signiﬁcant difference from the control wild-type group; *Indicates signiﬁcant difference
between scramble and CaV1.2 shRNA groups.
Fig. 3. CaV1.2 knockdown decreased cytosolic calcium levels in Pkd1−/− and Pkd2−/− cell
lines. Wild-type (WT), Pkd1−/− and Pkd2−/− cells were perfused with ﬂuid shear of
0.7 dyn/cm2 for 18 h. Cells were then loaded with Fura-2 for intracellular calcium mea-
surement. Unlikewild-type cells inwhichCaV1.2knockdownhadno effect on intracellular
calcium level, it signiﬁcantly decreased the already lower calcium levels in Pkd cells. N= 6
for each group. #Indicates signiﬁcant difference fromwild-type; *Indicates signiﬁcant dif-
ference between scramble and CaV1.2 shRNA groups.
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through cytosolic calcium and CaM kinase II.3.5. Effects of CaV1.2 knockdown on cell proliferation and polyploidy
PKD is characterized by abnormal cell proliferation and polyploidy
[21,22]. Therefore, we explored if CaV1.2 knockdown affected these
two factors. Our studies reinforced previous results that both Pkd1 and
Pkd2 were involved in abnormal cell proliferation and polyploidy
(Fig. 5a). Importantly, our studies further indicated that although
CaV1.2 knockdown (with shRNA) or CaV1.2 blockage (with verapamil)
had no effects onwild-type cells, it signiﬁcantly accelerated cell division
and polyploidy formation in both Pkd1 and Pkd2 cells. To further con-
ﬁrm our ﬂow cytometry analysis, we randomly selected 30 individual
cells with large nuclei from each group to directly count the number
of chromosomes (Fig. 5b). Chromosome numbers remained relatively
normal in wild-type cells without or with the CaV1.2 knockdown or
CaV1.2 blockage. Although Pkd cells were polyploidy, CaV1.2 knock-
down induced more polyploidy (≥4 N). Of note, many Pkd cells with
CaV1.2 knockdown had three times the normal number of chromo-
somes (≥6 N).
Fig. 4. CaV1.2 knockdown altered Akt and Erk phosphorylation in Pkd1−/− and Pkd2−/− cells. a. Immunoblottingwas performed to detect Akt and Erk phosphorylations inwild-type (WT),
Pkd1−/− and Pkd2−/− cells transfected with either scramble or CaV1.2 shRNA. Representative Western blots are shown, and W7 or KN-93 was used to block CaM Kinase II function.
b. Decreased Akt phosphorylation was detected in Pkd cells with CaV1.2 knockdown, while Erk phosphorylation was elevated in these cells. Phosphorylations of Akt and Erk were not
affected in wild-type cells with CaV1.2 silencing. N = 3 for each blot; #Indicates signiﬁcant difference from the wild-type control; *Indicates signiﬁcant difference between scramble
and CaV1.2 shRNA groups.
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mouse model
We have recently shown that abnormal cell division could induce
polyploidy, which could further promote cystic kidney formation in
zebraﬁsh and mice [21,22]. To investigate the pathophysiological roleof CaV1.2 in cyst formation, we utilized morpholino knockdown
approach in zebraﬁsh (Fig. 6a). Supporting our hypothesis of the
role of CaV1.2 in cyst formation, we consistently observed dilated
pronephric ducts in cav1.2 morpholino-knockdown ﬁsh. Unlike
in ﬁsh, however, knockdown of CaV1.2 in the wild-type mice did
not produce a cystic kidney (Fig. 6b). In Pkd1+/− mice (Mx1Cre:
Fig. 5. CaV1.2 knockdown accelerated cell proliferation and polyploidy in Pkd1−/− and Pkd2−/− cells. a. Flow cytometry analysis was carried out using propidium iodide (PI) to measure
DNA content. Cell proliferation and polyploidy formation were more pronounced in Pkd cells with CaV1.2 knockdown (to block expression) or verapamil treatment (to block function).
N = 5 for each group; #Indicates signiﬁcant difference from the wild-type (WT); *Indicates signiﬁcant difference between scramble and CaV1.2 shRNA (or verapamil treated) groups.
b. Polyploidy was further studied by directly counting the chromosome number from a single cell. A normal number of chromosomes (40) were observed in wild-type (WT) but not
Pkd cells. Severity in polyploidy as depicted by numbers of chromosomeswasmore evident in Pkd cells with CaV1.2 knockdown (KD) or verapamil treatment (VA) compared to scramble
control shRNA (C). N = 30 cells for each group.
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mice as young as two months old. Kidney to body weight ratio was
signiﬁcantly increased in Pkd1+/− mice with CaV1.2 knockdown
(Fig. 6c).4. Discussion
It has been well accepted that calcium ions play a signiﬁcant role
as a second messenger in translating extracellular stimulation into
Fig. 6. CaV1.2modulates cystic kidney formation in zebraﬁsh and Pkd1heterozygousmice. a.We usedmorpholino knockdown strategy to study the effect of CaV1.2 in zebraﬁsh. Compared
to scramblemorpholino, cav1.2morpholino resulted in pronephric duct dilations. Total count of the ﬁshwithout (non-cystic) andwith (cystic) pronephric duct dilation is tabulated in the
bar graph. Arrows indicate pronephric ducts. b. Lentiviral infection carrying scramble or CaV1.2 shRNAwasused in thewild-type (WT) or Pkd1heterozygousmice. Cystic kidney phenotype
could be easily observed from the isolated kidney. Further analysis indicated cystic-like phenotypes in Pkd1mice with shRNA knockdown. A total observation from individual animals
(n = 5–12) without or with cystic phenotype is summarized in the bar graph. c. Kidney to body weight ratio was signiﬁcantly increased in Pkd1mice with shRNA knockdown.
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for sensing cues from the extracellular environment, is also dependent
on calcium signaling to modulate cellular events such as mitosis,
proliferation, ﬂuid and ion transportation, cell volume regulation and
many others. Although many calcium channels have been studied in
the renal epithelium, not much effort was given to study voltage-
dependent calcium channels in the kidney. This was probably due tothe belief that the renal epithelium is not an excitable cell, unlike neu-
ron, myocyte or muscle cell. Thus, any changes in epithelial membrane
potential would be considered insigniﬁcant for voltage-operated
channels.
Interestingly, independent research groups have identiﬁed
voltage-dependent calcium channels, including L-type calcium
channel (CaV1.2), in renal epithelial cells [28,33,34]. Based on their
Fig. 7.Working model of renal CaV1.2. A schematic diagram depicts a hypothetical model
of CaV1.2 in cystic kidney phenotypes. The functional role of CaV1.2 can be modulated by
polycystins to regulate cytosolic calcium level. The calcium-signaling pathway involves
CaM kinase II, Akt and Erk, and it also plays important roles in cellular proliferation and
cell polyploidy. This in turn regulates structural maintenance of renal tubules.
1525X. Jin et al. / Biochimica et Biophysica Acta 1842 (2014) 1518–1526electrophysiological and pharmacological properties, voltage-dependent
calcium channels are categorized into four groups (L, N, T, and P). The
L-type Ca2+ channels are composed of multiple subunits (α1, α2, β, γ,
and δ). Some of these subunits express ubiquitously within the kidney,
including proximal tubules, medullary collecting ducts, cortical thick
ascending limbs, distal convoluted tubules, and cortical collecting ducts
[28]. Given the abundance of CaV1.2 within renal epithelial cells, it is
intriguing to understand its functionality in the kidney.
In the present study, we reported for the ﬁrst time that localization of
CaV1.2 to primary cilia was disrupted in Pkd cell lines. This indicates that
polycystins may regulate CaV1.2 ciliary localization. Furthermore, we
observed a signiﬁcantly higher expression level of CaV1.2 in Pkd cells.
Because polycystin-2 calcium channel (PC2) was also malfunctioned in
Pkd cells, we speculated that CaV1.2 could function in harmony with
PC2.We thus hypothesized that PC2 deﬁciencywould lead to compensa-
tory up-regulation of CaV1.2. In accordance with this view, the loss of
CaV1.2 did not have much effect on the intracellular calcium level in
normal wild-type kidney cells. However, when CaV1.2 expression was
suppressed in Pkd cells, a signiﬁcant decrease in intracellular calcium
level was observed. Because CaV1.2 knockdown did not induce cystic
kidney formation in wild-type mice, we would speculate that effects
of Pkd1 and Pkd2 on the CaV1.2 expression level would be less critical
in the context of cyst formation. Nonetheless, we could not rule
out the possibility of CaV1.2 overexpression in pathogenesis of renal
diseases.
Considering that the CaV1.2 expression level was signiﬁcantly
higher in Pkd cells than in wild-type cells, it is logical to speculate that
CaV1.2 would function as a secondary calcium-permeable channel to
the polycystin complex. In the presence of polycystins, the expression
of CaV1.2 was low, and so was its activity. When polycystins were not
functioning, up-regulation of CaV1.2 expression might be necessary to
compensate for the loss of the PC2 calcium channel. Depletion of
CaV1.2 in Pkd cells could therefore shut down this compensatorymech-
anism and consequently reduce the already lower intracellular calcium
concentration. Consistent with previous studies [3,16], such a discrep-
ancy in cytosolic calcium levels leads to an increased Erk activity in
PKD. Our studies also showed that the increased Erk activity could
also be reproduced by inhibition of CaM kinase activity in wild-type
cells. In wild-type cells, inhibiting CaM kinase II resulted in a low phos-
phorylated Akt level and consequently a higher Erk phosphorylation.
We therefore hypothesize that CaM kinase II plays a central role in the
association between intracellular calcium and downstream effectors,
such as Akt and Erk (Fig. 7).
On the cellular level, we observed that the length of primary cilia
was longer in Pkd cells compared to control wild-type cells.We have re-
cently shown that longer cilia tend to increase the sensitivity of renal
epithelial cells to ﬂuid-shear stress [26,27]. Thus, longer cilia in Pkd
cells might be caused by a compensatory response to further extend
the cilia length so the cells would be more sensitive to extracellular
stimulation. Equally interesting is that reducing CaV1.2 expression
in Pkd cells also resulted in shorter cilia. This might be a result of a
disrupted ciliary assembly that requires intracellular calcium. It is also
possible that CaV1.2 could interact with intraﬂagellarmolecules to facil-
itate cilia length maintenance.
Our studies also indicated that CaV1.2 modulated cell proliferation
and polyploidy formation in Pkd cells. By contrast, it did not have any
effect on wild-type cells. The differential effects of CaV1.2 between
wild-type and Pkd cells would very likely result from insufﬁcient intra-
cellular calcium in Pkd cells. This in turn leads to abnormal CaMkinase II,
Akt and Erk pathways. Our in vivo studies conﬁrmed the roles of CaV1.2
in kidney cyst formation. Renal cysts were consistently formed in wild-
type zebraﬁsh with cav1.2morpholino knockdown, unlike in wild-type
micewith CaV1.2 shRNA knockdown. This is probably due to less redun-
dancy in genetic makeup for zebraﬁsh compared to mice. Regardless,
our studies offer a unique correlation between the expression of
CaV1.2 and cystic kidneys. Taken together, we propose that CaV1.2may function as a genetic modiﬁer for Pkd, the loss of which aggravates
the cystic kidney phenotype.
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